Skip to main content
. 2019 Feb 5;19:47. doi: 10.1186/s12887-019-1420-z

Table 1.

Characteristics of the 666 children and adolescents enrolled in the EnPRISE study, 2015, Senegal

Characteristics n n % %
N 666
Gender (n = 666)
 Girl 328 49%
Age (n = 666)
 < 5 years 159 24%
 5–10 years 253 38%
 10–14 years 213 32%
 > 14 years 41 6%
Education (n = 666)
 No formal education 235 35%
 Educated 431 65%
  Primary 255 59%
  Arabic-Koranica 99 23%
  Secondary 47 11%
  Unavailable 30 7%
Family status (n = 666)
 Both parents alive 273 41%
 One parent alive 292 44%
 Orphans of both parents 101 15%
Testing of siblings (n = 666)
 No siblings 82 13%
 Siblings 485 72%
  No one tested 135 28%
  At least one tested 140 29%
  All tested 210 43%
 Unavailable 99 15%
Type of facility b (n = 666)
 Health Center 322 48%
 Level-I Hospital 141 21%
 Level-II Hospital 196 30%
 Level-III Hospital 7 1%
Responsible for treatment (n = 666)
 General practitioner 432 65%
 Pediatrician 234 35%
Disclosure (n = 666)
 Children < 8 years (not notified) 243 37%
 Age ≥ 8 years 300 45%
  Notified of status 42 14%
  Not notified of status 258 86%
 Unavailable 123 18%
Gateway to care c (n = 666)
 Care 347 52%
 Familial 270 40%
 PMTCT 12 2%
 Unavailable 37 6%
Regularity of follow-up d (n = 666)
 Regular 482 72%
 Not regular 128 19%
 Unavailable 56 9%
Prolonged treatment interruptions e (n=666)
 Yes 75 11%
 No 586 88%
 Unavailable 5 1%
Nutritional status f (n = 666)
 Normal 393 59%
 Moderate acute malnutrition (MAM) 95 14%
 Severe acute malnutrition (SAM) 87 13%
 Overweight 28 4%
 Unavailable 63 10%
Exposure to PMTCT (n = 666)
 Yes 45 7%
 No 468 70%
 Age < 10 years 412 88%
 Age ≥ 10 years 56 12%
 Unavailable 153 23%
ART Therapy (n = 666)
 Children untreated 65 10%
 Children treated 601 90%
Viral load (n = 666)
 Treatment ≤6 months 103 17%
 Treatment > 6 months 498 83%
 < 1000 cp/mL 178 36%
 ≥1000 cp/mL 320 64%
Duration of follow-up (treatment > 6 months n = 498)
 6–12 months 110 22%
 13–24 months 113 23%
 >  24 months 275 55%
Treatment regimen (treatment > 6 months n = 498) g
 AZT + 3TC + NVP/EFV 425 85%
 Other NRTI+NNRTI combinations 37 8%
 Combination with PI 36 7%
Adherence h (all children on treatment n = 601)
 Good 372 61%
 Average 81 13%
 Poor 61 10%
 Unavailable 87 14%

aFranco-Arabic/Koranic schools based on the study of the Koran and Arabic language

bLevel-I Hospital, departmental level; Level-II Hospital, regional level; Level-III Hospital, national level

cGateway to care: place of first consultation leading to HIV testing

dRegularity of follow-up: quarterly

eProlonged treatment interruptions: greater than one month

fNutritional status: based on WHO criteria

gTreatment regimen

hAdherence: estimated by physician